Xiaojun Zhou
- Topics
- Genetic factors in colorectal cancer (6 papers)Diabetes Treatment and Management (6 papers)Cancer-related molecular mechanisms research (6 papers)
- Partner nations
- ChinaUnited StatesAustralia
In The Last Decade
Xiaojun Zhou
67 papers receiving 697 citations
Peers
Comparison fields: 5 of 94
- Molecular Biology 269
- Cancer Research 150
- Surgery 149
- Endocrinology, Diabetes and Metabolism 136
- Oncology 126
Countries citing papers authored by Xiaojun Zhou
This map shows the geographic impact of Xiaojun Zhou's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Xiaojun Zhou with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Xiaojun Zhou more than expected).
Fields of papers citing papers by Xiaojun Zhou
This network shows the impact of papers produced by Xiaojun Zhou. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Xiaojun Zhou. The network helps show where Xiaojun Zhou may publish in the future.
Co-authorship network of co-authors of Xiaojun Zhou
This figure shows the co-authorship network connecting the top 25 collaborators of Xiaojun Zhou. A scholar is included among the top collaborators of Xiaojun Zhou based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Xiaojun Zhou. Xiaojun Zhou is excluded from the visualization to improve readability, since they are connected to all nodes in the network.
All Works
| # | Work | Indexed citations |
|---|---|---|
| 1 | 1 | |
| 2 | 0 | |
| 3 | 3 | |
| 4 | 2 | |
| 5 | 1 | |
| 6 | 3 | |
| 7 | 9 | |
| 8 | 1 | |
| 9 | 19 | |
| 10 | 5 | |
| 11 | 73 | |
| 12 | 6 | |
| 13 | 6 | |
| 14 | 12 | |
| 15 | 13 | |
| 16 | 19 | |
| 17 | 7 | |
| 18 | 3 | |
| 19 | RASSF1A expression inhibits cell growth and enhances cell chemosensitivity to mitomycin in BEL-7402 hepatocellular carcinoma cells. | 5 |
| 20 | 5 |
About Xiaojun Zhou
Xiaojun Zhou is a scholar working on Cancer Research, Endocrinology, Diabetes and Metabolism and Pathology and Forensic Medicine, having authored 69 papers that have together received 708 indexed citations. Recurring topics across this work include Genetic factors in colorectal cancer (6 papers), Diabetes Treatment and Management (6 papers) and Cancer-related molecular mechanisms research (6 papers). The work is most often cited by research in Cancer Research (150 citations), Endocrinology, Diabetes and Metabolism (136 citations) and Nephrology (52 citations). Xiaojun Zhou has collaborated with scholars based in China, United States and Australia. Frequent co-authors include Lin Liao, Jianjun Dong, Zhongwen Zhang, Junyu Zhao, Xue Shen, Jinming Yao, Chunmei Xu, Xiaoqian Zhang, Biao Liu and Lin Liao. Their work appears in journals such as Journal of Clinical Oncology, The FASEB Journal and British Journal of Pharmacology.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.